Follow the Biocon Limited stock price and the full directors' dealings record of the company, a listed issuer based in India. Shares are listed on IN IN, under the supervision of SEBI (PIT + SAST). Operating in the Health Care sector, Biocon Limited has recorded 275 reports. Market capitalisation: €408.7bn. The latest transaction was reported on 4 April 2024 (Pledge). Among the most active insiders: MANEESH H GHILDYAL. The full history is accessible without an account.
275
Insider Decl.
0
Thresholds
€28m
136 ops.
Buy Volume
€10m
127 ops.
Sell Volume
10Σ signal
Buys €28m€10m Sells
Informational score on this market. Our backtest validates the signal only on 8 EU venues; elsewhere (notably US markets) insider buys historically invert or do not hold. Not a recommendation.
Fundamental score
Ranked 7,182 of 25,571 companies
62.7
score / 100
Value
55
Quality
71
FCF yld4.2%
Earn yld2.5%
EV/EBITDA·
ROE·
Gross mgn65%
Net mgn6.7%
Debt/EBITDA·
Pillars2/3
Transparent value + quality ranking, distinct from the insider signal.
Σ
Sigma AI Analysis
Fundamental view, insider signal, bull and bear case, synthesis.
AI-generated analysis. Opinion, not investment advice. Not backtested. Built from public filings and financials. No price target, no buy or sell recommendation.